Healthcare & Life Sciences News and Articles

Google News – Clinical Trials External News

Pharmalittle: We're reading about another Novartis trial failure, a Novo Nordisk setback, and more - STAT

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

REGENERNON PHARMACEUTICALS, INC. (REGN) SHAREHOLDER ALERT - GlobeNewswire

news.google.com · 08 Sep 2026

Google News – Clinical Trials External News

Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 at Upcoming Medical Meetings - Investing News Network

news.google.com · 08 Sep 2026

Google News – Biopharma External News

Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business - PR Newswire

news.google.com · 08 Sep 2026

Google News – Biopharma External News

Aspire Biopharma changes name to Aspire-Lakewood Holdings - Investing.com

news.google.com · 08 Sep 2026

Google News – Biopharma External News

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc. - ACCESS Newswire

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

NRx Pharmaceuticals to Present at Three September Investor Conferences - citybiz

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Alebund Pharmaceuticals Receives FDA Clearance Of IND Application For AP308 For The Treatment Of IgA Nephropathy - marketscreener.com

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Amylyx Pharmaceuticals to Present at the 24th Annual Morgan Stanley Global Healthcare Conference - Business Wire

news.google.com · 08 Sep 2026

Google News – Biopharma External News

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc. - New Castle News

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know - Yahoo Finance

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Are Pharmaceutical Stocks Ready to Take Off? Here's What I See - Kiplinger

news.google.com · 08 Sep 2026

Google News – Oncology External News

Medicus Pharma Prioritises CD228V Oncology Programme in Development Strategy - Yahoo Finance

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome - The Manila Times

news.google.com · 08 Sep 2026

Google News – FDA (biotech/pharma) External News

Project Optimus explained: what the FDA expects on oncology dosing - The Pharma Letter

news.google.com · 08 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Pharmalittle: We're reading about another Novartis trial failure, a Novo Nordisk setback, and more - STAT

REGENERNON PHARMACEUTICALS, INC. (REGN) SHAREHOLDER ALERT - GlobeNewswire

Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 at Upcoming Medical Meetings - Investing News Network

Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business - PR Newswire

Aspire Biopharma changes name to Aspire-Lakewood Holdings - Investing.com

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc. - ACCESS Newswire

NRx Pharmaceuticals to Present at Three September Investor Conferences - citybiz

Alebund Pharmaceuticals Receives FDA Clearance Of IND Application For AP308 For The Treatment Of IgA Nephropathy - marketscreener.com

Amylyx Pharmaceuticals to Present at the 24th Annual Morgan Stanley Global Healthcare Conference - Business Wire

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc. - New Castle News

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know - Yahoo Finance

Are Pharmaceutical Stocks Ready to Take Off? Here's What I See - Kiplinger

Medicus Pharma Prioritises CD228V Oncology Programme in Development Strategy - Yahoo Finance

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome - The Manila Times

Project Optimus explained: what the FDA expects on oncology dosing - The Pharma Letter